UniProt ID | GTR1_HUMAN | |
---|---|---|
UniProt AC | P11166 | |
Protein Name | Solute carrier family 2, facilitated glucose transporter member 1 | |
Gene Name | SLC2A1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 492 | |
Subcellular Localization |
Cell membrane Multi-pass membrane protein. Melanosome. Localizes primarily at the cell surface. Identified by mass spectrometry in melanosome fractions from stage I to stage IV. |
|
Protein Description | Facilitative glucose transporter. This isoform may be responsible for constitutive or basal glucose uptake. Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses.. | |
Protein Sequence | MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFEMLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIMGNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHDLQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEKAGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQLPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGMCFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPEELFHPLGADSQV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEPSSKKL -------CCCCHHHH | 18.03 | 22814378 | |
4 | Phosphorylation | ----MEPSSKKLTGR ----CCCCHHHHHHH | 41.29 | 28509920 | |
5 | Phosphorylation | ---MEPSSKKLTGRL ---CCCCHHHHHHHH | 44.52 | 29083192 | |
45 | N-linked_Glycosylation | KVIEEFYNQTWVHRY HHHHHHHCCCCHHHC | 37.82 | 3839598 | |
45 | N-linked_Glycosylation | KVIEEFYNQTWVHRY HHHHHHHCCCCHHHC | 37.82 | 8662691 | |
113 | Phosphorylation | SAVLMGFSKLGKSFE HHHHHCHHHHCHHHH | 22.65 | 20860994 | |
118 | Phosphorylation | GFSKLGKSFEMLILG CHHHHCHHHHHHHHH | 25.33 | 20068231 | |
226 | Phosphorylation | NEENRAKSVLKKLRG CHHHHHHHHHHHHHC | 31.53 | 20815410 | |
234 | Phosphorylation | VLKKLRGTADVTHDL HHHHHHCCCCCHHCH | 17.16 | 25159151 | |
238 | Phosphorylation | LRGTADVTHDLQEMK HHCCCCCHHCHHHHH | 15.37 | 21712546 | |
244 | Sulfoxidation | VTHDLQEMKEESRQM CHHCHHHHHHHHHHH | 4.22 | 30846556 | |
245 | Ubiquitination | THDLQEMKEESRQMM HHCHHHHHHHHHHHH | 58.54 | 21906983 | |
245 | Acetylation | THDLQEMKEESRQMM HHCHHHHHHHHHHHH | 58.54 | 26051181 | |
248 | Phosphorylation | LQEMKEESRQMMREK HHHHHHHHHHHHHHH | 28.98 | 23025827 | |
258 | Phosphorylation | MMREKKVTILELFRS HHHHHCCHHHHHHCC | 28.82 | - | |
459 | Phosphorylation | VPETKGRTFDEIASG CCCCCCCCHHHHHHH | 44.07 | 29514088 | |
465 | Phosphorylation | RTFDEIASGFRQGGA CCHHHHHHHHHCCCC | 44.09 | 19664994 | |
465 | O-linked_Glycosylation | RTFDEIASGFRQGGA CCHHHHHHHHHCCCC | 44.09 | 19664994 | |
473 | Phosphorylation | GFRQGGASQSDKTPE HHHCCCCCCCCCCHH | 33.23 | 30266825 | |
475 | Phosphorylation | RQGGASQSDKTPEEL HCCCCCCCCCCHHHH | 38.28 | 30266825 | |
477 | Acetylation | GGASQSDKTPEELFH CCCCCCCCCHHHHCC | 71.83 | 26051181 | |
477 | Sumoylation | GGASQSDKTPEELFH CCCCCCCCCHHHHCC | 71.83 | - | |
477 | Ubiquitination | GGASQSDKTPEELFH CCCCCCCCCHHHHCC | 71.83 | 21906983 | |
478 | Phosphorylation | GASQSDKTPEELFHP CCCCCCCCHHHHCCC | 40.71 | 30266825 | |
490 | Phosphorylation | FHPLGADSQV----- CCCCCCCCCC----- | 32.10 | 19664994 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
226 | S | Phosphorylation |
| 25982116 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GTR1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CSN6_HUMAN | COPS6 | physical | 16169070 | |
FAK2_HUMAN | PTK2B | physical | 11007796 | |
CALX_HUMAN | CANX | physical | 8662691 | |
LMP1_EBVB9 | LMP1 | physical | 28732079 |
Kegg Disease | |
---|---|
H00831 | Primary dystonia |
H00836 | GLUT1 deficiency syndrome (GLUT1DS); Glucose transport defect of the blood-brain barrier |
OMIM Disease | |
606777 | GLUT1 deficiency syndrome 1 (GLUT1DS1) |
612126 | GLUT1 deficiency syndrome 2 (GLUT1DS2) |
614847 | Epilepsy, idiopathic generalized 12 (EIG12) |
601042 | Dystonia 9 (DYT9) |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00292 | Etomidate |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-45, AND MASS SPECTROMETRY. | |
"Sequence and structure of a human glucose transporter."; Mueckler M., Caruso C., Baldwin S.A., Panico M., Blench I.,Morris H.R., Allard W.J., Lienhard G.E., Lodish H.F.; Science 229:941-945(1985). Cited for: NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, GLYCOSYLATION ATASN-45, LACK OF GLYCOSYLATION AT ASN-411, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-490, AND MASSSPECTROMETRY. |